These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 21672514

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Modification of FP-HIV activity by peptide sequences of GB virus C: a biophysical approach.
    Domènech O, Ortiz A, Pujol M, Haro I, Muñoz M, Alsina MA, Prat J, Busquets MA, Girona V.
    Biochim Biophys Acta; 2014 May; 1838(5):1274-80. PubMed ID: 24530897
    [Abstract] [Full Text] [Related]

  • 4. A Langmuir monolayer study of the interaction of E1(145-162) hepatitis G virus peptide with phospholipid membranes.
    Sánchez-Martín MJ, Haro I, Alsina MA, Busquets MA, Pujol M.
    J Phys Chem B; 2010 Jan 14; 114(1):448-56. PubMed ID: 20000622
    [Abstract] [Full Text] [Related]

  • 5. Biophysical investigations of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide.
    Sánchez-Martín MJ, Urbán P, Pujol M, Haro I, Alsina MA, Busquets MA.
    Chemphyschem; 2011 Oct 24; 12(15):2816-22. PubMed ID: 21905195
    [Abstract] [Full Text] [Related]

  • 6. Physicochemical characterization of GBV-C E1 peptides as potential inhibitors of HIV-1 fusion peptide: interaction with model membranes.
    Sánchez-Martín MJ, Cruz A, Busquets MA, Haro I, Alsina MA, Pujol M.
    Int J Pharm; 2012 Oct 15; 436(1-2):593-601. PubMed ID: 22868231
    [Abstract] [Full Text] [Related]

  • 7. Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C.
    Sánchez-Martín MJ, Hristova K, Pujol M, Gómara MJ, Haro I, Alsina MA, Busquets MA.
    J Colloid Interface Sci; 2011 Aug 01; 360(1):124-31. PubMed ID: 21565353
    [Abstract] [Full Text] [Related]

  • 8. Study of the inhibition capacity of an 18-mer peptide domain of GBV-C virus on gp41-FP HIV-1 activity.
    Haro I, Gómara MJ, Galatola R, Domènech O, Prat J, Girona V, Busquets MA.
    Biochim Biophys Acta; 2011 Jun 01; 1808(6):1567-73. PubMed ID: 21377446
    [Abstract] [Full Text] [Related]

  • 9. Behaviour of a peptide sequence from the GB virus C/hepatitis G virus E2 protein in Langmuir monolayers: its interaction with phospholipid membrane models.
    Pérez-López S, Nieto-Suárez M, Mestres C, Alsina MA, Haro I, Vila-Romeu N.
    Biophys Chem; 2009 May 01; 141(2-3):153-61. PubMed ID: 19232456
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interfacial properties of a synthetic peptide derived from hepatitis G virus E2 protein: interaction with lipid monolayers.
    Casas J, Espina M, Haro M, Royo F, Alsina MA, Haro I, Mestres C.
    Langmuir; 2006 Jan 03; 22(1):246-54. PubMed ID: 16378428
    [Abstract] [Full Text] [Related]

  • 12. Interaction of GB virus C/hepatitis G virus synthetic peptides with lipid langmuir monolayers and large unilamellar vesicles.
    Pérez-López S, Vila-Romeu N, Asunción Alsina Esteller M, Espina M, Haro I, Mestres C.
    J Phys Chem B; 2009 Jan 08; 113(1):319-27. PubMed ID: 19195104
    [Abstract] [Full Text] [Related]

  • 13. The helical propensity of KLA amphipathic peptides enhances their binding to gel-state lipid membranes.
    Arouri A, Dathe M, Blume A.
    Biophys Chem; 2013 Jan 08; 180-181():10-21. PubMed ID: 23792704
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interaction of lipidated GBV-C/HGV NS3 (513-522) and (505-514) peptides with phospholipids monolayer. An AFM study.
    Weroński KJ, Diez-Pérez I, Busquets MA, López-Iglesias C, Girona V, Prat J.
    Colloids Surf B Biointerfaces; 2010 Jan 01; 75(1):25-33. PubMed ID: 19765957
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide.
    Herrera E, Gomara MJ, Mazzini S, Ragg E, Haro I.
    J Phys Chem B; 2009 May 21; 113(20):7383-91. PubMed ID: 19402654
    [Abstract] [Full Text] [Related]

  • 18. Biophysical characterization of the fusogenic region of HCV envelope glycoprotein E1.
    Pérez-Berná AJ, Pabst G, Laggner P, Villalaín J.
    Biochim Biophys Acta; 2009 Oct 21; 1788(10):2183-93. PubMed ID: 19698697
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Structure and orientation study of Ebola fusion peptide inserted in lipid membrane models.
    Agopian A, Castano S.
    Biochim Biophys Acta; 2014 Jan 21; 1838(1 Pt B):117-26. PubMed ID: 24055820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.